Fred Alger Management’s Epizyme, Inc EPZM Stock Holding History

Fred Alger Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-57,000	Closed	-$715K	–	556
2019 Q2	$715K	Buy	57,000 +47,000	+470%	+$605K	﹤0.01%	361
2019 Q1	$124K	Hold	10,000	–	–	﹤0.01%	403
2018 Q4	$62K	Buy	+10,000	New	+$76.4K	﹤0.01%	393
2018 Q2	–	Sell	-20,000	Closed	-$355K	–	599
2018 Q1	$355K	Buy	+20,000	New	+$338K	﹤0.01%	384
2016 Q1	–	Sell	-60,250	Closed	-$965K	–	616
2015 Q4	$965K	Buy	+60,250	New	+$893K	﹤0.01%	385

Other funds holding EPZM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fred Alger Management's EPZM Position: Q3 2019 in Review

Fred Alger Management sold out of Epizyme, Inc (EPZM) in Q3 2019, closing a stake of 57,000 shares — an estimated $715K sold.

Fred Alger Management first reported a position in EPZM in Q4 2015 and held it in 5 quarters. The position peaked at $965K in Q4 2015. 115 funds tracked by Wall St. Rank hold EPZM as of Q3 2019.

Fred Alger Management reported no remaining Epizyme, Inc position as of Q3 2019 after selling out during the quarter.
Fred Alger Management sold 57,000 Epizyme, Inc shares in Q3 2019, an estimated $715K.
Fred Alger Management first reported a position in Epizyme, Inc in Q4 2015 and held it in 5 quarters.
Fred Alger Management's Epizyme, Inc position peaked at $965K in Q4 2015.
115 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2019.

Based on Fred Alger Management's 13F filing for Q3 2019, filed 14 Nov 2019.